Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Every two seconds, a person in the U.S. needs blood. The American Red Cross is struggling to keep up with demand.
Patient access to the opioid-overdose reversal drug naloxone, sold under the brand name Narcan, has expanded in both Texas and Florida. CVS Health has made naloxone available without prescription at all pharmacy locations across Texas and Florida, allowing patients and…
The Drug Enforcement Agency believes hundreds of thousands of counterfeit prescription pills laced with a powerful opioid have entered the U.S. drug market, according to The Guardian.
The Food and Drug Administration denied approval for Bedford, Mass.-based Ocular Therapeutix's new eye drug Dextenza.
The Food and Drug Administration granted Kenilworth, N.J.-based Merck's experimental Ebola virus vaccine with a Breakthrough Therapy Designation.
How far will physicians go to get their dying patients a new heart?
By early 2013, the Japanese medical device manufacturer Olympus was already facing superbug outbreaks in three nations linked to their duodenoscopes. However, the company advised their U.S. executives against issuing warnings to hospitals about potentially contaminated scopes, according to information…
Inhalers used to treat asthma and chronic lung disease will soon be getting an upgrade.
QuVa Pharma, a sterile compounding pharmaceutical company, recently acquired a new biotech facility in New Jersey.
What's worse: importing drug ingredients from a Chinese factory with known quality control issues or experiencing a shortage in the U.S. of crucial cancer drugs?